全球肾功能测试市场 – 行业趋势和 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球肾功能测试市场 – 行业趋势和 2029 年预测

  • In Vitro Diagnostics
  • Upcoming Report
  • Oct 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Kidney Function Tests Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2022 –2029
Diagram Market Size (Base Year)
USD 823.68 Million
Diagram Market Size (Forecast Year)
USD 1,312.83 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

全球肾功能测试市场,按测试类型(稀释和浓度测试、清除测试、尿液测试、影像测试、血液测试)、产品类型(试纸、一次性用品、试剂)、最终用途(医院、诊断实验室、研究实验室和研究所)划分 - 行业趋势和预测到 2029 年。  

肾功能测试市场

 肾功能测试市场分析和规模

这些功能中的任何一个发生紊乱,都会导致废物排泄减少,从而导致废物在体内积聚,或导致体内某些重要营养物质流失。根据尿液和血液中这些排泄物和营养物质的水平,我们可以进行精确的计算,以了解肾脏执行其各种功能的效率。

Data Bridge Market Research 分析称,2021 年肾功能测试市场规模为 8.2368 亿美元,预计到 2029 年将达到 13.1283 亿美元,2022 年至 2029 年预测期内的复合年增长率为 6.00%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

肾功能测试市场范围和细分

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制为 2014 - 2019)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

测试类型(稀释和浓度测试、清除测试、尿液测试、影像测试、血液测试)、产品类型(试纸、一次性用品、试剂)、最终用途(医院、诊断实验室、研究实验室和研究所)

覆盖国家

北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区。

涵盖的市场参与者

Abbott (U.S.), Akers Biosciences, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eurofins Scientific (Luxembourg), Boston Heart Diagnostics Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Home Access Health (U.S.), Laboratory Corporation of America Holdings (U.S.), PRIMA Lab SA (Switzerland), Quest Diagnostics Incorporated (U.S.), Randox Laboratories Ltd. (U.K.), Sekisui Diagnostics (U.S.), Siemens (Germany), Merck KGaA (Germany), Siemens Healthcare Private Limited (Germany),  Danaher (U.S.), Sysmex Corporation (Japan), Nova Biomedical (U.S.)

Market Opportunities

  • Rising kidney related diseases
  • Rising personal disposable income in the developing economies

Market Definition

Kidney function tests are a group of lab tests that include urine analysis, blood urea nitrogen (BUN), and serum creatinine tests, among others, to examine the normal functioning of the kidneys. They are extremely useful in determining the normal functions of the renal tissues as well as detecting any abnormalities or health anomalies, such as acute/chronic kidney disease, polycystic kidney disease, diabetic nephropathy, kidney failure, and glomerulonephritis. Kidney function tests are blood tests or urine tests that evaluate how well your kidneys are working. Most of the tests measure glomerular filtration rate (GFR). Glomerular filtration rate assesses how efficiently your kidneys clear waste from your system. The main function of the kidney would be the excretion of water-soluble waste products from our body. The kidney has various filtration, excretion, and secretory functions. A group of tests that help to evaluate the function of kidneys to enable early diagnosis and prevention of worsening of disease. Wastes and excess fluid are removed from the blood by healthy kidneys. Blood and urine tests show how well the kidneys are working and how quickly wastes are removed from the body. Urine tests can also detect if the kidneys are leaking excessive amounts of protein, which is a sign of kidney damage.

Global Kidney Function Tests Market Dynamics

Drivers

  • Technological innovations are driving the market

Rising innovation and technological advancement which is the first systems for treating kidney failure were developed in the 1940's, when it was found that blood could be successfully cleared of toxins and returned to the body using a relatively simple device based on artificial sausage skin wrapped around a wooden frame) will further increase a number of prospects that will drive the growth of the kidney function testing market throughout the course of the above mentioned forecast period.

  • Development of novel products is also bolstering growth

Rising R&D initiatives for the development of novel products are expected to significantly boost market growth during the forecast period. For instance, in January 2020, Germany-based SphingoTec GmbH launched its IB10 sphingotest penKid, a Point-of-Care (PoC) test for Proenkephalin (penKid). This biomarker enables real-time evaluation of kidney function with a normal blood test. In addition, growing investments in the field of kidney function testing are further expected to fuel the market growth. In January 2020, Sweden-based Elypta AB raised a seed round worth USD 7.0 million to develop the first urine test for kidney cancer.

Opportunities

  • Government initiatives

Several public-private partnerships are launching initiatives to make kidney disease testing more accessible in key areas. For instance, in July 2020, the National Kidney Foundation (NKF) introduced a new kidney health evaluation measure, specifically for diabetes patients, in collaboration with the National Committee for Quality Assurance (NCQA). The new guidelines recommend that diabetic patients be routinely tested for kidney disease. Such initiatives are expected to foster a favourable environment for market expansion.

Restraints/Challenges

  • High cost of kidney related tests

High cost of kidney function tests and the low adoption rate in emerging and underdeveloped countries will obstruct the market's growth rate. The greater number of individuals with a clinical diagnosis of kidney disease as a result of the modified formula would mean that more people may receive recommendations for dose adjustments or contraindications for certain drugs that may interfere with kidney function or be poorly filtered by the kidneys.

This kidney function tests market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the kidney function tests market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent developments

  • In August 2021, ID Genomics (IDG), a Seattle-based company, invented a dipstick-based assay for the simultaneous identification of a large number of genetic variants of SARS-CoV2 and received a grant of USD 300,000 from the National Institute of Health (NIH).
  • In July 2022, bioMérieux received FDA approval for the innovative VIDAS NEPHROCHECK assay to detect kidney stress in patients at risk of acute kidney injury (AKI). The introduction of new products and the region's growing advances in urine analysis are driving market growth.

全球肾功能测试市场范围

肾功能测试市场根据测试类型、产品类型和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

测试类型

  • 稀释和浓度测试
  • 清除测试
  • 尿液检测
  • 影像学检查
  • 验血
  • 血清肌酐检测
  • 血尿素氮检测
  • 肾小球滤过率测试

 产品类型

  • 量油尺
  • 一次性用品
  • 试剂

 最终用途

  • 医院
  • 诊断实验室
  • 研究实验室和研究所

肾功能测试市场区域分析/见解

对肾功能测试市场进行了分析,并按国家、测试类型、产品类型、最终用户提供了市场规模见解和趋势。

肾功能测试市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于人们对 CKD 的认知度高,以及有利的报销政策和政府举措,北美在肾功能测试市场占据主导地位。美国在北美区域市场中占据领先地位。其占据主导地位的关键因素包括主要市场参与者的本地存在以及技术先进产品的易得性。

由于医疗保健设施的快速发展和主要市场参与者的投资增加,预计亚太地区将在 2022 年至 2029 年的预测期内实现最高增长率。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

肾功能测试市场还为您提供每个国家/地区资本设备医疗保健支出增长、肾功能测试市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对肾功能测试市场的影响的详细市场分析。数据涵盖 2010-2020 年的历史时期。

竞争格局和肾功能测试市场份额分析

肾功能测试市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对肾功能测试市场的关注有关。

肾功能测试市场的一些主要参与者包括:

  • 雅培(美国)
  • Akers Biosciences, Inc.(美国)
  • 贝克曼库尔特公司(美国)
  • Bio-Rad Laboratories, Inc.(美国)
  • Eurofins Scientific(卢森堡)
  • 波士顿心脏诊断公司(美国)
  • F. Hoffmann-La Roche Ltd(瑞士)
  • 家庭健康通道(美国)
  • 美国实验室控股公司(美国)
  • PRIMA Lab SA(瑞士)
  • Quest Diagnostics Incorporated(美国)
  • Randox Laboratories Ltd.(英国)
  • Sekisui Diagnostics(美国)
  • 西门子(德国)
  • 默克集团(德国)
  • 西门子医疗私人有限公司(德国)
  •  丹纳赫(美国)
  •  Sysmex 公司 (日本)
  •  Nova Biomedical(美国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The kidney function tests market value was USD 823.68 million in 2021.
The kidney function tests market is projected to grow at a CAGR of 6.00% during the forecast period of 2022-2029.
North America dominates the kidney function tests market due to the high awareness levels about CKD, and favorable reimbursement policies and government initiatives.
The top players in the market are Abbott (U.S.), Akers Biosciences, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eurofins Scientific (Luxembourg), Boston Heart Diagnostics Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Home Access Health (U.S.), Laboratory Corporation of America Holdings (U.S.), PRIMA Lab SA (Switzerland), Quest Diagnostics Incorporated (U.S.), Randox Laboratories Ltd. (U.K.), Sekisui Diagnostics (U.S.), Siemens (Germany), Merck KGaA (Germany), Siemens Healthcare Private Limited (Germany), Danaher (U.S.), Sysmex Corporation (Japan), Nova Biomedical (U.S.)